Search

AF solution

Chevron

Infectious disease

As a virus-infected model, the utilization of tonsil, adenoid, and lung organoids allows for the evaluation of antiviral drug efficacy and facilitates virus research.

Starting cost
0 +

Infectious disease

This model allows researchers to study the dynamics of viral entry, replication, and host response within the tonsil organoid system.
Lambda provides a comprehensive solution, offering the service of applying antiviral treatments such as Remdesivir.
This allows for an investigation into their therapeutic efficacy in reducing viral replication.

Cell Type

· ASC

Organoid type

· Tonsil organoid

This model allows researchers to study the dynamics of viral entry, replication, and host response within the adenoid organoid system.
Lambda provides a comprehensive solution, offering the service of applying antiviral treatments.
This allows for an investigation into their therapeutic efficacy in reducing viral replication.

Cell Type

· ASC

Organoid type

· Adenoid organoid

Lung organoids, mimicking the human lung, are instrumental in respiratory infection research.
Lambda specifically employs patient-derived lung organoids for assessing the effectiveness of antiviral drugs.
This approach enhances our understanding of disease pathogenesis, aids in drug discovery, contributes to vaccine development, and provides a physiologically relevant platform for studying host-pathogen interactions.

Cell Type

· ASC

Organoid type

· Lung organoid

Assay

Respiratory tract infection

Lung organoids, mimicking the human lung, are instrumental in respiratory infection research.
Lambda specifically employs patient-derived lung organoids for assessing the effectiveness of antiviral drugs.
This approach enhances our understanding of disease pathogenesis, aids in drug discovery, contributes to vaccine development,
and provides a physiologically relevant platform for studying host-pathogen interactions.

Assay process

Technical

Morphology analysis & qPCR

The lung organoids underwent treatment with an anti-viral drug, both before and after virus infection, with observations conducted at different drug concentrations.
As the drug concentration increased, there was a notable trend of decreasing virus titers, confirming the drug’s effectiveness in reducing the viral presence.

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.